Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 24.12.2025 SDVY.LN IE0001R850E1 10,754,007.00 USD 251,858,334.53 23.420  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 24.12.2025 FTGS.LN IE000YZLMXT9 25,002.00 USD 561,854.21 22.472  ...

LONDON--(BUSINESS WIRE)--  Re: First Abu Dhabi Bank P.J.S.C. AUD 35,000,000.00 MATURING: 29-Jun-2026 ISIN: XS2358731177 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 29-Dec-2025 TO 30-Mar-2026 HAS BEEN FIXED AT 4.48 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 30-Mar-2026 WILL AMOUNT TO: AUD 11,169.32 PER AUD 1,000,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 24.12.2025 GFEB.LN IE000X8M8M80 700,002.00 USD 25,978,231.49 37.112  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 24.12.2025 KNG.LN IE000SNMGYT5 200,002.00 USD 4,105,236.16 20.526  ...

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers résistants et métastatiques, et Navigo Proteins GmbH (Halle, Allemagne) entreprise biopharmaceutique spécialisée dans la découverte et le développement de nouvelles approches de médecine de précision basées sur la plateforme technologique Affilin®, annoncent conjointement...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Envision Healthcare completes agreements with Arizona Blue, strengthening access to in-network care for its members across the state...

ANTWERPEN, België--(BUSINESS WIRE)--Regulatory News: In overeenstemming met artikel 14 van de Belgische Transparantiewet van 2 mei 2007 maakt Azelis Group NV (Brussels:AZE) bekend dat het een transparantiekennisgeving heeft ontvangen van First Pacific Advisors, LP. 1. Samenvatting van de kennisgeving First Pacific Advisors, LP heeft in de kennisgeving gedateerd op 22 december 2025 gemeld dat op 16 december 2025, na een vervreemding van effecten met stemrecht, First Pacific Advisors, LP haar dee...

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, and Navigo Proteins GmbH (Halle, Germany), a biopharmaceutical company specializing in the discovery and development of new precision medicine approaches based on the Affilin® technology platform, jointly announce the termination of their collaboration agre...

ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: In accordance with Article 14 of the Belgian Transparency law of May 2, 2007, Azelis Group NV (Brussels:AZE) announces that it has received a transparency notification from First Pacific Advisors, LP. 1. Summary of the notification First Pacific Advisors, LP reported in its notification dated 22 December 2025, that on 16 December 2025, following a disposal of voting securities, First Pacific Advisors, LP decreased its participation and downwar...